人工气胸辅助单孔胸腔镜胸腺切除术在胸腺肿瘤患者中的应用

Abstract
Figure/Table
References (15)
Related Citation (4)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application of artificial pneumothorax assisted with single-port thoracoscopic thymectomy in patients with thymic tumors. Methods From September 2016 to December 2018, a total of 28 patients with thymic tumor underwent artificial pneumothorax assisted with single-port thoracoscopic thymectomy were selected as the experimental group, and a total of 38 patients with thymic tumor who underwent artificial pneumothorax assisted thoracoscopic (three hole) thymectomy in the same period were selected as the control group. The experimental group was treated with artificial pneumothorax assisted with single-port thoracoscopic thymectomy, while the control group was treated with artificial pneumothorax assisted thoracoscopic (three hole) thymectomy. The operation time,intraoperative blood loss, postoperative drainage volume and postoperative hospital stay were compared between the two groups. Results There were no significant differences in operation time, intraoperative blood loss, postoperative hospital stay, postoperative chest tube placement time, pathological type and the proportion of 26F drainage tube between the two groups (P＞0.05). The visual analogue pain score of the experimental group at 24 h after operation was lower than that of the control group, and the difference was statistically significant (P＜0.05). Both groups recovered well after operation, without complications or perioperative death, and there was no recurrence after 6 to 18 months follow-up.Conclusion Artificial pneumothorax assisted with singl-port thoracoscopic thymectomy is feasible and safe for patients with thymic tumor.

Key words： Artificial Pneumothorax Singl-port Thoracoscopic Thymectomy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIE Jin-bao
	DU Quan
	LIN Min
	TU Yuan-rong
	CHEN Jian-feng

Cite this article:

XIE Jin-bao,DU Quan,LIN Min, et al. Application of artificial pneumothorax assisted with single-port thoracoscopic thymectomy in patients with thymic tumors[J]. 中国当代医药, 2020, 27(28): 113-116.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I28/113

[1]	Watanabe SN，Imai K，Kimura T，et al.Effect of lidocaine cream analgesia for chest drain tube removal after video-assisted thoracoscopic surgery for lung cancer：a randomized clinical trial[J].Reg Anesth Pain Med，2019. [Online ahead of print].
[2]	Shen Y，Zhou Y，Zhuang X.An improved method for gastric tube and anastomotic anvil placement during thoracoscopic and laparoscopic Ivor Lewis esophagectomy[J].World J Surg Oncol，2020，18（1）：110.
[3]	Ueda K，Aoki M，Maeda K，et al.Thoracoscopic en bloc resection of left upper lobe lung cancer[J].Multimed Man Cardiothorac Surg，2019. [Online ahead of print].
[4]	Qiu T，Zhao Y，Xuan Y，et al.Robotic sleeve lobectomy for centrally located non-small cell lung cancer：a propensity score-weighted comparison with thoracoscopic and open surgery[J].J Thorac Cardiovasc Surg，2020，160（3）：838-846，e2.
[5]	Li P，Li S，Che G.Role of chest tube drainage in physical function after thoracoscopic lung resection[J].J Thorac Dis，2019，11（Suppl 15）：S1947-S1950.
[6]	Ergun E，Ates U，Bahadir K，et al.A Safe and Minimally Invasive Method for Thoracoscopic Lung Biopsy in Interstitial Lung Disease[J].Pediatr Allergy Immunol Pulmonol，2019，32（3）：117-120.
[7]	Hua K，Yang S，Zhang Y，et al.Thoracoscopic surgery for recurrent tracheoesophageal fistula after esophageal atresia repair[J].Dis Esophagus，2020，33（9）：doaa023.
[15]	唐桂旺，叶敬霆，武强，等.不同种手术方式治疗胸腺瘤合并重症肌无力的比较[J].中国胸心血管外科临床杂志，2018，25（9）：767-771.
[8]	Cheng X，Huang J，Li J，et al.Reply to the comments on′Three-arm robot-assisted thoracoscopic surgery for locally advanced N2 non-small cell lung cancer′，a better technique，new territory，and future hopes[J].J Thorac Dis，2019，11（10）：E198-E199.
[9]	Akar E，Haberal MA，Dikis OS.Diagnostic and therapeutic treatment methods for intrathoracic extrapulmonary lipomas[J].Niger J Clin Pract，2020，23（5）：626-630.
[10]	Motus I，Skorniakov SN，Kil′diusheva EI，et al.Artificial pneumothorax in the treatment of destructive pulmonary tuberculosis complicated by its drug-resistant pathogen[J].Probl Tuberk Bolezn Legk，2005，（12）：22-26.
[11]	Trojan A，Bohm T，Kurrer MO.Non-Hodgkin′s lymphoma of the pleural cavity：late complication of artificial pneumothorax for the treatment of pulmonary tuberculosis[J].Swiss Med Wkly，2001，131（11-12）：164.
[12]	Use of artificial pneumothorax and pneumoperitoneum in the treatment of destructive pulmonary tuberculosis under present conditions[J].Probl Tuberk，2003，（2）：50-53.
[13]	Bilgi Z，Swanson SJ. Current indications and outcomes for thoracoscopic segmentectomy for early stage lung cancer[J].J Thorac Dis，2019，11（Suppl 13）：S1662-S1669.
[14]	Kamiya I.A case of T-cell malignant lymphoma developing in the chest wall of chronic pyothorax after artificial pneumothorax[J].Nihon Kyobu Geka Gakkai Zasshi，1996，44（5）：709-713.